← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 21, 2020Last known activity
Nov 25, 2025
Timeline
1990s
- Nov 26, 1998
China National Pharmaceutical Group— Founded
Drugs by trial phase (18 distinct, 21 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (21)
- NCT07300644Lead sponsorPhase 2Nov 25, 2025
- NCT06939777Lead sponsorPhase 1/Phase 2Apr 30, 2025
- NCT06800261Lead sponsorPhase 1Apr 30, 2025
- NCT06967272Lead sponsorPhase 2Jan 20, 2025
- NCT06617715Lead sponsorPhase 3Oct 12, 2024
- NCT06550830Lead sponsorPhase 1Aug 28, 2024
- NCT06474377Lead sponsorPhase 1Jun 20, 2024
- NCT06950645Lead sponsorPhase 1Mar 27, 2024
- NCT06049940Lead sponsorPhase 3Sep 1, 2023
- NCT06042764Lead sponsorPhase 2Aug 31, 2023
- NCT06050460Lead sponsorPhase 1Jun 15, 2023
- NCT06048393Lead sponsorPhase 1May 31, 2023
- NCT05667714Lead sponsorN/ANov 26, 2022
- NCT05593042CollaboratorPhase 2Oct 31, 2022
- NCT05664919Lead sponsorN/AOct 30, 2022
Details
- Founded
- Beijing, CN Nov 26, 1998
- Last known activity
- Nov 25, 2025